- Home
- GEL vs DNLI Comparison
GEL vs DNLI Comparison
Compare GEL & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEL
- DNLI
- Stock Information
- Founded
- GEL 1996
- DNLI 2013
- Country
- GEL United States
- DNLI United States
- Employees
- GEL N/A
- DNLI N/A
- Industry
- GEL Oil Refining/Marketing
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GEL Energy
- DNLI Health Care
- Exchange
- GEL Nasdaq
- DNLI Nasdaq
- Market Cap
- GEL 2.1B
- DNLI 2.1B
- IPO Year
- GEL 1996
- DNLI 2017
- Fundamental
- Price
- GEL $16.73
- DNLI $15.45
- Analyst Decision
- GEL Buy
- DNLI Strong Buy
- Analyst Count
- GEL 3
- DNLI 15
- Target Price
- GEL $19.50
- DNLI $33.62
- AVG Volume (30 Days)
- GEL 454.0K
- DNLI 1.8M
- Earning Date
- GEL 10-30-2025
- DNLI 08-11-2025
- Dividend Yield
- GEL 3.93%
- DNLI N/A
- EPS Growth
- GEL N/A
- DNLI N/A
- EPS
- GEL N/A
- DNLI N/A
- Revenue
- GEL $2,877,249,000.00
- DNLI N/A
- Revenue This Year
- GEL N/A
- DNLI N/A
- Revenue Next Year
- GEL $10.26
- DNLI $802.87
- P/E Ratio
- GEL N/A
- DNLI N/A
- Revenue Growth
- GEL 17.61
- DNLI N/A
- 52 Week Low
- GEL $9.86
- DNLI $10.57
- 52 Week High
- GEL $17.77
- DNLI $33.33
- Technical
- Relative Strength Index (RSI)
- GEL 46.88
- DNLI 58.65
- Support Level
- GEL $16.66
- DNLI $15.20
- Resistance Level
- GEL $17.36
- DNLI $16.00
- Average True Range (ATR)
- GEL 0.44
- DNLI 0.71
- MACD
- GEL -0.03
- DNLI 0.08
- Stochastic Oscillator
- GEL 24.76
- DNLI 73.76
About GEL Genesis Energy L.P. Common Units
Genesis Energy LP is a limited partnership company that focuses on the midstream segment of the crude oil and natural gas industry. It engages in providing services to crude oil and natural gas producers, and industrial and commercial enterprises. The company's reportable segments are offshore pipeline transportation, sodium minerals, and sulfur services, onshore facilities and transportation, and marine transportation. It generates maximum revenue from the offshore pipeline transportation segment which conducts crude oil and natural gas pipeline transportation and handling operations in the Gulf of Mexico through its offshore pipeline transportation segment, which focuses on providing a suite of services to integrated and large independent energy companies.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.